Structural studies

Contact

  • http://regulation.plan.be

The pharmaceutical industry in Belgium - Competitiveness analysis [09/05/2019]

This Working Paper analyses the competitive position of the pharmaceutical industry over the 2000-2017 period. The evolution of price/cost competitiveness and non-cost competitiveness is studied based on a comparison with our neighbouring countries France, the Netherlands and Germany, and with Denmark, Ireland, Slovenia and Switzerland. The study also analyses a series of global factors and factors specific to the pharmaceutical industry that may influence competitiveness.

Tax incentives for business R&D in Belgium - Third evaluation [07/05/2019]

Belgium has committed to raise investment in research and development (R&D) to 3% of GDP by 2020. In fulfilment of this commitment, the federal government introduced different tax incentives in support of business R&D. This paper presents the results of the third evaluation of the efficiency of these tax incentives, covering the period 2003-2015.

Contact

  • http://regulation.plan.be

Better understanding the Belgian economy’s structural evolutions and its insertion in both the European Union and the world plays an important role in identifying the key factors of long-term growth.

  The last five press releases [More]

  The last five databases [More]

  The last five publications [More]

Contact

  • http://regulation.plan.be
Please do not visit, its a trap for bots